Privium Fund Management’s Pfizer PFE Stock Holding History

Privium Fund Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-52,679	Closed	-$1.48M	–	66
2026 Q1	$1.48M	Buy	52,679 +14,929	+40%	+$397K	0.31%	40
2025 Q4	$940K	Hold	37,750	–	–	0.17%	42
2025 Q3	$962K	Buy	37,750 +721	+2%	+$17.8K	0.17%	42
2025 Q2	$927K	Buy	37,029 +4,702	+15%	+$110K	0.2%	33
2025 Q1	$819K	Buy	32,327 +10,349	+47%	+$271K	0.21%	34
2024 Q4	$583K	Hold	21,978	–	–	0.13%	43
2024 Q3	$636K	Sell	21,978 -14,142	-39%	-$413K	0.16%	41
2024 Q2	$1.01M	Buy	36,120 +6,960	+24%	+$192K	0.26%	43
2024 Q1	$809K	Buy	29,160 +9,017	+45%	+$250K	0.22%	50
2023 Q4	$599K	Buy	+20,143	New	+$609K	0.17%	56
2023 Q3	–	Sell	-14,473	Closed	-$523K	–	124
2023 Q2	$523K	Buy	14,473 +7,710	+114%	+$300K	0.15%	56
2023 Q1	$276K	Buy	+6,763	New	+$292K	0.09%	64

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Privium Fund Management's PFE Position: Q2 2026 in Review

Privium Fund Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 52,679 shares — an estimated $1.48M sold.

Privium Fund Management first reported a position in PFE in Q1 2023 and held it in 12 quarters. The position peaked at $1.48M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Privium Fund Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
Privium Fund Management sold 52,679 Pfizer shares in Q2 2026, an estimated $1.48M.
Privium Fund Management first reported a position in Pfizer in Q1 2023 and held it in 12 quarters.
Privium Fund Management's Pfizer position peaked at $1.48M in Q1 2026.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Privium Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.